A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine

Mucosal Immunology

Volumn 8, Issue 3, 2015, Pages 607-617

  Dunne, A ^a   Mielke, L A ^a   Allen, A C ^a   Sutton, C E ^a   Higgs, R ^a   Cunningham, C C ^a   Higgins, S C ^a   Mills, K H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; IMMUNOGLOBULIN G2A ANTIBODY; LIPOPROTEIN; LIPOPROTEIN BP 1569; PERTUSSIS VACCINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CYTOKINE; IMMUNOLOGICAL ADJUVANT; SUBUNIT VACCINE; TLR2 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BORDETELLA PERTUSSIS; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TH1 CELL; TH17 CELL; TH2 CELL; AGONISTS; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELLULAR IMMUNITY; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; VACCINATION; WHOOPING COUGH;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LIPOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; PERTUSSIS VACCINE; TH1 CELLS; TH17 CELLS; TOLL-LIKE RECEPTOR 2; VACCINATION; VACCINES, SUBUNIT; WHOOPING COUGH;

EID: 84928899001     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.93     Document Type: Article

References (32)

1. Cherry, J.D. The present and future control of pertussis. Clin. Infect. Dis. 51, 663-667 (2010).
2. Higgs, R., Higgins, S.C., Ross, P.J. & Mills, K.H. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 5, 485-500 (2012).
3. Mooi, F.R., Van Der Maas, N.A. & De Melker, H.E. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol. Infect. 142, 1-10 (2013).
4. Klein, N.P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B. & Baxter, R. Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med. 367, 1012-1019 (2012).
5. Ryan, E.J., Nilsson, L., Kjellman, N., Gothefors, L. & Mills, K.H. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 121, 193-200 (2000).
6. Ryan, M. et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93, 1-10 (1998).
7. Redhead, K., Watkins, J., Barnard, A. & Mills, K.H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61, 3190-3198 (1993).
8. Ausiello, C.M., Urbani, F., la Sala, A., Lande, R. & Cassone, A. Vaccine-and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65, 2168-2174 (1997).
9. Ross, P.J. et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 9, e1003264 (2013).
10. Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16-34 (2011).
11. Higgins, S.C., Jarnicki, A.G., Lavelle, E.C. & Mills, K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177, 7980-7989 (2006).
12. Higgins, S.C. et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171, 3119-3127 (2003).
13. Donnelly, S., Loscher, C.E., Lynch, M.A. & Mills, K.H. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in anew murine model for analysis of neuronal side effects of vaccination. Infect. Immun. 69, 4217-4223 (2001).
14. Dunne, A. et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185, 1711-1719 (2010).
15. Morr, M., Takeuchi, O., Akira, S., Simon, M.M. & Muhlradt, P.F. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32, 3337-3347 (2002).
16. Takeuchi, O. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933-940 (2001).
17. Takeuchi, O. et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14 (2002).
18. Braun, V. & Rehn, K. Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure. Eur. J. Biochem. 10, 426-438 (1969).
19. Hantke, K. & Braun, V. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur. J. Biochem. 34, 284-296 (1973).
20. Braun, V. Covalent lipoprotein from the outermembrane of Escherichia coli. Biochim. Biophys. Acta 415, 335-377 (1975).
21. Jin, M.S. et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082 (2007).
22. Fennelly, N.K. et al. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect. Immun. 76, 1257-1266 (2008).
23. Punturieri, A., Copper, P., Polak, T., Christensen, P.J. & Curtis, J.L. Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages. J. Immunol. 177, 673-680 (2006).
24. Sutton, C.E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from gamma delta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009).
25. Martin, B., Hirota, K., Cua, D.J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
26. Sutton, C.E., Mielke, L.A. & Mills, K.H. IL-17-producing gammadelta Tcells and innate lymphoid cells. Eur. J. Immunol. 42, 2221-2231 (2012).
27. Mahon, B.P., Brady, M.T. & Mills, K.H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J. Infect. Dis. 181, 2087-2091 (2000).
28. Walsh, K.P. & Mills, K.H. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 34, 521-530 (2013).
29. Warfel, J.M., Zimmerman, L.I. & Merkel, T.J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 111, 787-792 (2014).
30. Carpenter, S. et al. TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain. J. Immunol. 183, 3989-3995 (2009).
31. Sutherland, J.N., Chang, C., Yoder, S.M., Rock, M.T. & Maynard, J.A. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clin. Vaccine Immunol. 18, 954-962 (2011).
32. McGuirk, P., McCann, C. & Mills, K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231 (2002).